J R Masters. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » Administration, IntravesicalAfrican AmericansAntineoplastic Agents/administration & dosageAntineoplastic Agents/therapeutic useCarcinoma, Transitional Cell/drug therapyCarcinoma, Transitional Cell/mortalityClinical Trials, Phase III as TopicDrug ResistanceEpirubicin/administration & dosageEpirubicin/therapeutic useHumansHydrogen-Ion ConcentrationMitomycin/administration & dosageMitomycin/therapeutic useMulticenter Studies as TopicOsmolar ConcentrationRandomized Controlled Trials as TopicUrinary Bladder Neoplasms/drug therapyUrinary Bladder Neoplasms/mortality
Substances： See more » Antineoplastic AgentsEpirubicinMitomycin
Year: 2001 PMID： 11604485 DOI： 10.1093/jnci/93.20.1574
Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506